When looking at geographies, the US accounts for approximately 32.7% of total activity, making it the clear leader in the global Alzheimer’s disease landscape.
When looking at geographies, the US accounts for approximately 32.7% of total activity, making it the clear leader in the global Alzheimer’s disease landscape.